Inhalation Sciences Sweden AbNGM: ISAB

ISAB: Revenue and order intake surged, losses narrowed, and acquisition talks are advancing

· Issued by Inhalation Sciences Sweden AB

Revenue and order intake grew sharply year-over-year, supported by strong execution and new orders. Operating losses narrowed, and the acquisition process is progressing with a target to conclude before summer 2026.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Earlier from Inhalation Sciences Sweden Ab

All Inhalation Sciences Sweden Ab news releases